Literature DB >> 22362854

Quadriceps wasting and physical inactivity in patients with COPD.

Dinesh Shrikrishna1, Mehul Patel, Rebecca J Tanner, John M Seymour, Bronwen A Connolly, Zudin A Puthucheary, Simon L F Walsh, Susannah A Bloch, Paul S Sidhu, Nicholas Hart, Paul R Kemp, John Moxham, Michael I Polkey, Nicholas S Hopkinson.   

Abstract

Quadriceps weakness is an important complication of advanced chronic obstructive pulmonary disease (COPD) but few data exist concerning muscle bulk in early disease. We hypothesised that quadriceps bulk, measured by ultrasound rectus femoris cross-sectional area (USRF(CSA)), would be reduced in mild, as well as advanced, COPD compared with controls, and would correlate with physical activity. 161 patients with stable COPD and 40 healthy subjects had a measurement of USRF(CSA) and wore a multisensor armband to record physical activity. USRF(CSA) was reduced in Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage I patients compared with healthy subjects (p=0.0002). Stage II-IV patients had reduced USRF(CSA) (p<0.0001) compared with controls but were not significantly different from those with stage I disease. Physical activity level was reduced in stage I (p=0.002) and stage II-IV disease compared with controls. Using regression analysis, physical activity level was independently associated with USRF(CSA) in stage I (p=0.01) but not stage II-IV disease, where residual volume to total lung capacity ratio was the only independent predictor of physical activity level. Quadriceps wasting exists in patients with mild, as well as advanced, COPD, and is independently associated with physical inactivity in GOLD stage I disease. The identification of these patients may guide early lifestyle and therapeutic interventions.

Entities:  

Mesh:

Year:  2012        PMID: 22362854     DOI: 10.1183/09031936.00170111

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  103 in total

Review 1.  Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-04-06       Impact factor: 2.444

2.  Muscle dysfunction in patients with lung diseases: a growing epidemic.

Authors:  Esther Barreiro; Jacob I Sznajder; Gustavo A Nader; G R Scott Budinger
Journal:  Am J Respir Crit Care Med       Date:  2015-03-15       Impact factor: 21.405

Review 3.  Imaging approaches to understand disease complexity: chronic obstructive pulmonary disease as a clinical model.

Authors:  Karin J C Sanders; Samuel Y Ash; George R Washko; Felix M Mottaghy; Annemie M W J Schols
Journal:  J Appl Physiol (1985)       Date:  2017-07-27

4.  Bedside assessment of quadriceps muscle by ultrasound after admission for acute exacerbations of chronic respiratory disease.

Authors:  Neil J Greening; Theresa C Harvey-Dunstan; Emma J Chaplin; Emma E Vincent; Mike D Morgan; Sally J Singh; Michael C Steiner
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 21.405

Review 5.  Sarcopenia and frailty in chronic respiratory disease.

Authors:  Anna E Bone; Nilay Hepgul; Samantha Kon; Matthew Maddocks
Journal:  Chron Respir Dis       Date:  2017-02-24       Impact factor: 2.444

Review 6.  Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction.

Authors:  Joaquim Gea; Carme Casadevall; Sergi Pascual; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

7.  Vastus lateralis fiber shift is an independent predictor of mortality in chronic obstructive pulmonary disease.

Authors:  Mehul S Patel; Samantha A Natanek; Grigorios Stratakos; Sergi Pascual; Juana Martínez-Llorens; Laura Disano; Gerasimos Terzis; Nicholas S Hopkinson; Joaquim Gea; Ioannis Vogiatzis; François Maltais; Michael I Polkey
Journal:  Am J Respir Crit Care Med       Date:  2014-08-01       Impact factor: 21.405

8.  Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial.

Authors:  Michael I Polkey; Jens Praestgaard; Amy Berwick; Frits M E Franssen; Dave Singh; Michael C Steiner; Richard Casaburi; Hanns-Christian Tillmann; Estelle Lach-Trifilieff; Ronenn Roubenoff; Daniel S Rooks
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 21.405

9.  Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.

Authors:  Ariel Jaitovich; Esther Barreiro
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

10.  Can Sarcopenia Quantified by Ultrasound of the Rectus Femoris Muscle Predict Adverse Outcome of Surgical Intensive Care Unit Patients as well as Frailty? A Prospective, Observational Cohort Study.

Authors:  Noomi Mueller; Sushila Murthy; Christopher R Tainter; Jarone Lee; Kathleen Riddell; Florian J Fintelmann; Stephanie D Grabitz; Fanny P Timm; Benjamin Levi; Tobias Kurth; Matthias Eikermann
Journal:  Ann Surg       Date:  2016-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.